Questions: Endocrine Glands and Hormonal Signaling

Question 1

Why do steroid hormones (e.g., cortisol) generally have a slower onset of action than peptide hormones (e.g., insulin), even though steroids are lipid-soluble and can enter cells directly?

• A. Steroids must first be activated by an enzyme in the bloodstream before they can bind receptors
• B. Steroids act via cytoplasmic/nuclear receptors and alter gene transcription, requiring hours for new proteins to be synthesized; peptides act via membrane receptors and second messengers that activate pre-existing proteins in seconds
• C. Steroid receptors are located only in bone cells, making distribution slower
• D. Peptide hormones travel faster in the bloodstream because they are smaller molecules

Answer: (B)

Lipid solubility lets steroids diffuse into cells and bind intracellular (cytoplasmic or nuclear) receptors. The receptor-hormone complex then acts as a transcription factor, altering gene expression. Producing new mRNA and translating it into functional proteins takes hours to days. Peptide hormones bind membrane surface receptors and activate second-messenger cascades (cAMP, IP3, DAG) that modify existing enzymes immediately — hence the rapid, transient effects.

Question 2

Because steroid hormones are lipid-soluble and enter cells easily, they act more rapidly than water-soluble peptide hormones, which should work through surface receptors.

• T. True
• F. False

Answer: False

This is a common and important misconception. Lipid solubility determines where the receptor is (inside the cell vs. on the membrane), not how fast the response is. Steroids bind nuclear receptors and change gene expression — a slow process requiring new protein synthesis (hours to days). Peptide hormones activate pre-existing signaling proteins via second messengers, producing effects within seconds to minutes. Faster access to the receptor does not mean faster physiological effect.

Question 3

Trace the negative feedback loop of the hypothalamic-pituitary-thyroid (HPT) axis, starting from low blood thyroid hormone levels.

Model answer: Low thyroid hormone is detected by the hypothalamus, which secretes TRH (thyrotropin-releasing hormone). TRH stimulates the anterior pituitary to release TSH (thyroid-stimulating hormone). TSH acts on the thyroid gland to increase synthesis and release of T3 and T4. Rising T3/T4 levels then feed back negatively to suppress both TRH release from the hypothalamus and TSH release from the pituitary, restoring homeostasis.

Negative feedback loops are the dominant control mechanism in the endocrine system. The key feature is that the end product (T3/T4) inhibits its own production pathway at multiple levels (hypothalamus and pituitary). This multi-level inhibition allows fine-grained control and redundancy. Understanding this loop helps predict clinical outcomes: primary hypothyroidism (damaged thyroid) will show high TSH because the pituitary is trying to compensate; secondary hypothyroidism (pituitary failure) will show low TSH.